Osimertinib for NSCLC With Uncommon EGFR Mutations

Clinical trial NCT05421936 · SUSPENDED

Trial details

NCT number: NCT05421936
Sponsor: Sheba Medical Center
Status: SUSPENDED
Study type: OBSERVATIONAL

Carcinoma, Non-Small-Cell Lung Genes, erbB-1

Start date: 2020-09-27
Primary completion: 2024-09-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.